Clinical Trials Logo

Clinical Trial Summary

Determine the effects of 8 week Investigational Supplement on cellular detoxification and gene expression profiles


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Supportive Care


Related Conditions & MeSH terms


NCT number NCT01598272
Study type Interventional
Source Pharmanex
Contact
Status Completed
Phase Phase 4
Start date July 2011
Completion date June 2012

See also
  Status Clinical Trial Phase
Recruiting NCT05813379 - Mesenchymal Stem Cells Derived Exosomes in Skin Rejuvenation Phase 1/Phase 2